These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19747472)

  • 21. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
    Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
    Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating nucleic acids in plasma and serum: recent developments.
    Swaminathan R; Butt AN
    Ann N Y Acad Sci; 2006 Sep; 1075():1-9. PubMed ID: 17108186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker.
    Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L
    Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of circulating DNA in the plasma and serum of cancer patients.
    Taback B; O'Day SJ; Hoon DS
    Ann N Y Acad Sci; 2004 Jun; 1022():17-24. PubMed ID: 15251934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia.
    Müller I; Urban K; Pantel K; Schwarzenbach H
    Ann N Y Acad Sci; 2006 Sep; 1075():222-9. PubMed ID: 17108215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic developments involving cell-free (circulating) nucleic acids.
    Tong YK; Lo YM
    Clin Chim Acta; 2006 Jan; 363(1-2):187-96. PubMed ID: 16126188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
    Tost J
    Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MeInfoText: associated gene methylation and cancer information from text mining.
    Fang YC; Huang HC; Juan HF
    BMC Bioinformatics; 2008 Jan; 9():22. PubMed ID: 18194557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation and hepatocellular carcinoma.
    Zhu J
    J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
    Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating nucleic acids in cancer and pregnancy.
    Pinzani P; Salvianti F; Pazzagli M; Orlando C
    Methods; 2010 Apr; 50(4):302-7. PubMed ID: 20146940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum DNA as a tool for cancer patient management.
    Ramirez JL; Taron M; Balaña C; Sarries C; Mendez P; de Aguirre I; Nuñez L; Roig B; Queralt C; Botia M; Rosell R
    Rocz Akad Med Bialymst; 2003; 48():34-41. PubMed ID: 14737938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.